Skip to main content

Table 1 Baseline characteristics of 33 patients with locally recurrent NPC

From: Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition?

Characteristic

Number of patients (%)

Sex

Male

26 (78.79)

Female

7 (21.21)

Age (years)

Mean ± SD

48.64 ± 10.29

 ≥ 50

14 (42.42)

 < 50

19 (57.58)

Tumor category

T1

5 (15.15)

T2

6 (18.18)

T3

11 (33.33)

T4

11 (33.33)

Node category

N0

2 (6.06)

N1

13 (39.39)

N2

14 (42.42)

N3

4 (12.12)

Clinical stage

II

3 (9.09)

III

15 (45.45)

IVa

15 (45.45)

SUVmax in primary tumor

Mean ± SD

11.43 ± 5.17

SUVmax in recurrent tumor

Mean ± SD

7.73 ± 4.06

Vpri in primary tumor (SUV = 2.5)

Median (range)

22.85 (4.16–105.09) cm3

Vhigh in primary tumor (SUV50%max)

Median (range)

5.57 (0–43.07) cm3

Vrecur in recurrent tumor (SUV = 2.5)

Median (range)

9.98 (0.32–59.46) cm3

  1. SD Standard deviations, SUV Standardized uptake value, Vpri The primary tumor volume using the SUV thresholds of 2.5, Vhigh The volume of high FDG uptake using the SUV50%max isocontour, Vrecur The recurrent tumor volume using the SUV thresholds of 2.5